ID   LDHB_HUMAN              Reviewed;         334 AA.
AC   P07195;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 204.
DE   RecName: Full=L-lactate dehydrogenase B chain;
DE            Short=LDH-B;
DE            EC=1.1.1.27;
DE   AltName: Full=LDH heart subunit;
DE            Short=LDH-H;
DE   AltName: Full=Renal carcinoma antigen NY-REN-46;
GN   Name=LDHB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2930497; DOI=10.1042/bj2570921;
RA   Takeno T., Li S.S.-L.;
RT   "Structure of the human lactate dehydrogenase B gene.";
RL   Biochem. J. 257:921-924(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RX   PubMed=3435492; DOI=10.1042/bj2480933;
RA   Sakai I., Sharief F.S., Pan Y.-C.E., Li S.S.-L.;
RT   "The cDNA and protein sequences of human lactate dehydrogenase B.";
RL   Biochem. J. 248:933-936(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-23; 44-58; 78-100; 108-113; 120-127; 159-170;
RP   234-244; 271-279 AND 300-329, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 8-23; 44-58; 78-91; 108-113; 120-127; 159-170;
RP   234-244; 280-299 AND 300-318, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND TYR-240, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7; LYS-58; LYS-119 AND
RP   LYS-329, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-240, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH NADH AND
RP   SUBSTRATE ANALOG, AND HOMOTETRAMERIZATION.
RX   PubMed=11276087;
RX   DOI=10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#;
RA   Read J.A., Winter V.J., Eszes C.M., Sessions R.B., Brady R.L.;
RT   "Structural basis for altered activity of M- and H-isozyme forms of
RT   human lactate dehydrogenase.";
RL   Proteins 43:175-185(2001).
RN   [16]
RP   VARIANT LDHBD GLU-7.
RX   PubMed=8314553; DOI=10.1007/BF00217765;
RA   Maekawa M., Sudo K., Kitajima M., Matsuura Y., Li S.S.-L., Kanno T.;
RT   "Analysis of a genetic mutation in an electrophoretic variant of the
RT   human lactate dehydrogenase-B(H) subunit.";
RL   Hum. Genet. 91:423-426(1993).
RN   [17]
RP   VARIANTS LDHBD GLU-35; VAL-171 AND LEU-175.
RX   PubMed=8462975; DOI=10.1007/BF00222718;
RA   Maekawa M., Sudo K., Kitajima M., Matsuura Y., Li S.S.-L., Kanno T.;
RT   "Detection and characterization of new genetic mutations in
RT   individuals heterozygous for lactate dehydrogenase-B(H) deficiency
RT   using DNA conformation polymorphism analysis and silver staining.";
RL   Hum. Genet. 91:163-168(1993).
RN   [18]
RP   VARIANTS LDHBD ARG-129 AND HIS-172.
RX   PubMed=1587525; DOI=10.1007/BF00217116;
RA   Sudo K., Maekawa M., Tomonaga A., Tsukada T., Nakayama T.,
RA   Kitamura M., Li S.S.-L., Kanno T., Toriumi J.;
RT   "Molecular characterization of genetic mutations in human lactate
RT   dehydrogenase (LDH) B (H) variant.";
RL   Hum. Genet. 89:158-162(1992).
RN   [19]
RP   VARIANT LDHBD HIS-172.
RX   PubMed=2334429; DOI=10.1016/0006-291X(90)92373-8;
RA   Sudo K., Maekawa M., Ikawa S., Machida K., Kitamura M., Li S.S.-L.;
RT   "A missense mutation found in human lactate dehydrogenase-B (H)
RT   variant gene.";
RL   Biochem. Biophys. Res. Commun. 168:672-676(1990).
RN   [20]
RP   VARIANT LDHBD VAL-322.
RA   Maekawa M., Sudo K., Fujita K., Yoshioka N., Sakurabayashi I.,
RA   Li S.S.-L., Kanno T.;
RT   "DNA analysis of slow type of electrophoretic lactate dehydrogenase
RT   B(H) variant.";
RL   Seibutsu Butsuri Kagaku 38:25-29(1994).
RN   [21]
RP   VARIANT LDHBD TRP-107.
RX   PubMed=8611651; DOI=10.1016/0925-4439(95)00089-5;
RA   Shonnard G.C., Hud N.V., Mohrenweiser H.W.;
RT   "Arginine to tryptophan substitution in the active site of a human
RT   lactate dehydrogenase variant -- LDHB GUA1: postulated effects on
RT   subunit structure and catalysis.";
RL   Biochim. Biophys. Acta 1315:9-14(1996).
RN   [22]
RP   VARIANT LDHBD ASN-223 DEL.
RX   PubMed=10211631; DOI=10.1016/S0009-9120(98)00097-6;
RA   Sudo K., Maekawa M., Houki N., Okuda T., Akizuki S., Magara T.,
RA   Kawano K.;
RT   "A novel in-frame deletion mutation in a case of lactate dehydrogenase
RT   (LD) H subunit deficiency showing an atypical LD isoenzyme pattern in
RT   serum and erythrocytes.";
RL   Clin. Biochem. 32:137-141(1999).
RN   [23]
RP   VARIANT LDHBD PRO-172.
RX   PubMed=9929983; DOI=10.1007/s100380050111;
RA   Hidaka K., Ueda N., Hirata I., Watanabe Y., Minatogawa Y., Iuchi I.;
RT   "First case of missense mutation (LDH-H:R171P) in exon 4 of the
RT   lactate dehydrogenase gene detected in a Japanese patient.";
RL   J. Hum. Genet. 44:69-72(1999).
RN   [24]
RP   VARIANT LDHBD GLU-69.
RX   PubMed=11509017; DOI=10.1006/mgme.2001.3203;
RA   Takatani T., Takaoka N., Tatsumi M., Kawamoto H., Okuno Y., Morita K.,
RA   Masutani T., Murakawa K., Okamoto Y.;
RT   "A novel missense mutation in human lactate dehydrogenase b-subunit
RT   gene.";
RL   Mol. Genet. Metab. 73:344-348(2001).
CC   -!- CATALYTIC ACTIVITY: (S)-lactate + NAD(+) = pyruvate + NADH.
CC   -!- PATHWAY: Fermentation; pyruvate fermentation to lactate; (S)-
CC       lactate from pyruvate: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:11276087}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-358748, EBI-358748;
CC       Q93050:ATP6V0A1; NbExp=2; IntAct=EBI-358748, EBI-2891238;
CC       P00338-3:LDHA; NbExp=8; IntAct=EBI-358748, EBI-10195200;
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-358748, EBI-5323863;
CC       P50542:PEX5; NbExp=3; IntAct=EBI-358748, EBI-597835;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-358748, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DISEASE: Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]:
CC       A condition with no deleterious effects on health. LDHBD is of
CC       interest to laboratory medicine mainly because it can cause
CC       misdiagnosis in those disorders in which elevation of serum LDH is
CC       expected. {ECO:0000269|PubMed:10211631,
CC       ECO:0000269|PubMed:11509017, ECO:0000269|PubMed:1587525,
CC       ECO:0000269|PubMed:2334429, ECO:0000269|PubMed:8314553,
CC       ECO:0000269|PubMed:8462975, ECO:0000269|PubMed:8611651,
CC       ECO:0000269|PubMed:9929983, ECO:0000269|Ref.20}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. LDH family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Lactate dehydrogenase entry;
CC       URL="https://en.wikipedia.org/wiki/Lactate_dehydrogenase";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Another dark horse -
CC       Issue 109 of September 2009;
CC       URL="http://web.expasy.org/spotlight/back_issues/109";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13794; CAA32033.1; -; Genomic_DNA.
DR   EMBL; X13795; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; X13796; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; X13797; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; X13798; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; X13799; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; X13800; CAA32033.1; JOINED; Genomic_DNA.
DR   EMBL; Y00711; CAA68701.1; -; mRNA.
DR   EMBL; BC002362; AAH02362.1; -; mRNA.
DR   EMBL; BC015122; AAH15122.1; -; mRNA.
DR   EMBL; BC071860; AAH71860.1; -; mRNA.
DR   CCDS; CCDS8691.1; -.
DR   PIR; S02795; DEHULH.
DR   RefSeq; NP_001167568.1; NM_001174097.2.
DR   RefSeq; NP_001302466.1; NM_001315537.1.
DR   RefSeq; NP_002291.1; NM_002300.7.
DR   UniGene; Hs.446149; -.
DR   PDB; 1I0Z; X-ray; 2.10 A; A/B=2-334.
DR   PDB; 1T2F; X-ray; 3.00 A; A/B/C/D=2-332.
DR   PDBsum; 1I0Z; -.
DR   PDBsum; 1T2F; -.
DR   ProteinModelPortal; P07195; -.
DR   SMR; P07195; -.
DR   BioGrid; 110137; 135.
DR   IntAct; P07195; 29.
DR   MINT; MINT-1144561; -.
DR   STRING; 9606.ENSP00000229319; -.
DR   BindingDB; P07195; -.
DR   ChEMBL; CHEMBL4940; -.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB03940; Oxamic Acid.
DR   iPTMnet; P07195; -.
DR   PhosphoSitePlus; P07195; -.
DR   SwissPalm; P07195; -.
DR   BioMuta; LDHB; -.
DR   DMDM; 126041; -.
DR   DOSAC-COBS-2DPAGE; P07195; -.
DR   OGP; P07195; -.
DR   REPRODUCTION-2DPAGE; IPI00219217; -.
DR   SWISS-2DPAGE; P07195; -.
DR   UCD-2DPAGE; P07195; -.
DR   EPD; P07195; -.
DR   PaxDb; P07195; -.
DR   PeptideAtlas; P07195; -.
DR   PRIDE; P07195; -.
DR   TopDownProteomics; P07195; -.
DR   DNASU; 3945; -.
DR   Ensembl; ENST00000350669; ENSP00000229319; ENSG00000111716.
DR   Ensembl; ENST00000396076; ENSP00000379386; ENSG00000111716.
DR   GeneID; 3945; -.
DR   KEGG; hsa:3945; -.
DR   CTD; 3945; -.
DR   DisGeNET; 3945; -.
DR   GeneCards; LDHB; -.
DR   HGNC; HGNC:6541; LDHB.
DR   HPA; CAB004641; -.
DR   HPA; HPA019007; -.
DR   MalaCards; LDHB; -.
DR   MIM; 150100; gene.
DR   MIM; 614128; phenotype.
DR   neXtProt; NX_P07195; -.
DR   OpenTargets; ENSG00000111716; -.
DR   Orphanet; 284435; Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency.
DR   PharmGKB; PA30325; -.
DR   eggNOG; KOG1495; Eukaryota.
DR   eggNOG; COG0039; LUCA.
DR   GeneTree; ENSGT00550000074541; -.
DR   HOGENOM; HOG000213793; -.
DR   HOVERGEN; HBG000462; -.
DR   InParanoid; P07195; -.
DR   KO; K00016; -.
DR   OMA; CNDKLQG; -.
DR   OrthoDB; EOG091G0HME; -.
DR   PhylomeDB; P07195; -.
DR   TreeFam; TF314963; -.
DR   BRENDA; 1.1.1.27; 2681.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   SABIO-RK; P07195; -.
DR   UniPathway; UPA00554; UER00611.
DR   ChiTaRS; LDHB; human.
DR   EvolutionaryTrace; P07195; -.
DR   GenomeRNAi; 3945; -.
DR   PRO; PR:P07195; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111716; -.
DR   CleanEx; HS_LDHB; -.
DR   ExpressionAtlas; P07195; baseline and differential.
DR   Genevisible; P07195; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0004459; F:L-lactate dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0006089; P:lactate metabolic process; IEA:Ensembl.
DR   GO; GO:0019674; P:NAD metabolic process; IEA:Ensembl.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   HAMAP; MF_00488; Lactate_dehydrog; 1.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR011304; L-lactate_DH.
DR   InterPro; IPR018177; L-lactate_DH_AS.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF56327; SSF56327; 1.
DR   TIGRFAMs; TIGR01771; L-LDH-NAD; 1.
DR   PROSITE; PS00064; L_LDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; NAD; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.4}.
FT   CHAIN         2    334       L-lactate dehydrogenase B chain.
FT                                /FTId=PRO_0000168459.
FT   NP_BIND      31     53       NAD. {ECO:0000250}.
FT   ACT_SITE    194    194       Proton acceptor.
FT   BINDING     100    100       NAD. {ECO:0000269|PubMed:11276087}.
FT   BINDING     107    107       Substrate.
FT   BINDING     139    139       NAD or substrate.
FT                                {ECO:0000269|PubMed:11276087}.
FT   BINDING     170    170       Substrate.
FT   BINDING     249    249       Substrate.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.4}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00338}.
FT   MOD_RES       7      7       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      18     18       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P00338}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      58     58       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      82     82       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00338}.
FT   MOD_RES     119    119       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     127    127       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00338}.
FT   MOD_RES     240    240       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     319    319       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00338}.
FT   MOD_RES     329    329       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT       7      7       K -> E (in LDHBD; slightly decreased
FT                                activity; dbSNP:rs118203897).
FT                                {ECO:0000269|PubMed:8314553}.
FT                                /FTId=VAR_004173.
FT   VARIANT      35     35       A -> E (in LDHBD).
FT                                {ECO:0000269|PubMed:8462975}.
FT                                /FTId=VAR_004174.
FT   VARIANT      69     69       G -> E (in LDHBD).
FT                                {ECO:0000269|PubMed:11509017}.
FT                                /FTId=VAR_011634.
FT   VARIANT     107    107       R -> W (in LDHBD; inactive;
FT                                dbSNP:rs777954556).
FT                                {ECO:0000269|PubMed:8611651}.
FT                                /FTId=VAR_011635.
FT   VARIANT     129    129       S -> R (in LDHBD; dbSNP:rs118203896).
FT                                {ECO:0000269|PubMed:1587525}.
FT                                /FTId=VAR_004175.
FT   VARIANT     171    171       F -> V (in LDHBD).
FT                                {ECO:0000269|PubMed:8462975}.
FT                                /FTId=VAR_004176.
FT   VARIANT     172    172       R -> H (in LDHBD; dbSNP:rs118203895).
FT                                {ECO:0000269|PubMed:1587525,
FT                                ECO:0000269|PubMed:2334429}.
FT                                /FTId=VAR_004177.
FT   VARIANT     172    172       R -> P (in LDHBD).
FT                                {ECO:0000269|PubMed:9929983}.
FT                                /FTId=VAR_011636.
FT   VARIANT     175    175       M -> L (in LDHBD).
FT                                {ECO:0000269|PubMed:8462975}.
FT                                /FTId=VAR_004178.
FT   VARIANT     175    175       M -> V (in dbSNP:rs7966339).
FT                                /FTId=VAR_049758.
FT   VARIANT     223    223       Missing (in LDHBD).
FT                                {ECO:0000269|PubMed:10211631}.
FT                                /FTId=VAR_011637.
FT   VARIANT     322    322       D -> V (in LDHBD). {ECO:0000269|Ref.20}.
FT                                /FTId=VAR_004179.
FT   VARIANT     325    325       W -> R (in LDHBD; dbSNP:rs267607212).
FT                                /FTId=VAR_011638.
FT   HELIX         4      8       {ECO:0000244|PDB:1I0Z}.
FT   STRAND        9     13       {ECO:0000244|PDB:1T2F}.
FT   STRAND       21     27       {ECO:0000244|PDB:1I0Z}.
FT   HELIX        31     42       {ECO:0000244|PDB:1I0Z}.
FT   STRAND       47     52       {ECO:0000244|PDB:1I0Z}.
FT   HELIX        56     68       {ECO:0000244|PDB:1I0Z}.
FT   HELIX        69     72       {ECO:0000244|PDB:1I0Z}.
FT   STRAND       76     80       {ECO:0000244|PDB:1I0Z}.
FT   HELIX        84     87       {ECO:0000244|PDB:1I0Z}.
FT   STRAND       91     95       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       107    110       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       111    128       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      133    136       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      138    140       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       141    152       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       156    158       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      159    161       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       165    179       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       183    185       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      190    192       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       202    204       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       212    215       {ECO:0000244|PDB:1I0Z}.
FT   TURN        217    220       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      221    223       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      225    227       {ECO:0000244|PDB:1T2F}.
FT   HELIX       229    246       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       251    265       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      270    277       {ECO:0000244|PDB:1I0Z}.
FT   TURN        279    282       {ECO:0000244|PDB:1T2F}.
FT   STRAND      289    297       {ECO:0000244|PDB:1I0Z}.
FT   STRAND      300    304       {ECO:0000244|PDB:1I0Z}.
FT   HELIX       311    328       {ECO:0000244|PDB:1I0Z}.
SQ   SEQUENCE   334 AA;  36638 MW;  3AD605DEED0D54A2 CRC64;
     MATLKEKLIA PVAEEEATVP NNKITVVGVG QVGMACAISI LGKSLADELA LVDVLEDKLK
     GEMMDLQHGS LFLQTPKIVA DKDYSVTANS KIVVVTAGVR QQEGESRLNL VQRNVNVFKF
     IIPQIVKYSP DCIIIVVSNP VDILTYVTWK LSGLPKHRVI GSGCNLDSAR FRYLMAEKLG
     IHPSSCHGWI LGEHGDSSVA VWSGVNVAGV SLQELNPEMG TDNDSENWKE VHKMVVESAY
     EVIKLKGYTN WAIGLSVADL IESMLKNLSR IHPVSTMVKG MYGIENEVFL SLPCILNARG
     LTSVINQKLK DDEVAQLKKS ADTLWDIQKD LKDL
//
